Neurocrine Biosciences shares owned by PENN Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by PENN Capital Management
from 13F filings
Historical chart of PENN Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by PENN Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by PENN Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.8M | 11k | 170.48 |
| 2022-12-31 | $391k | 3.3k | 119.44 |
| 2022-09-30 | $356k | 3.4k | 106.08 |
| 2022-06-30 | $342k | 3.5k | 97.44 |
| 2022-03-31 | $334k | 3.6k | 93.64 |
| 2021-12-31 | $245k | 2.9k | 85.19 |
| 2021-09-30 | $275k | 2.9k | 95.95 |
| 2021-06-30 | $293k | 3.0k | 97.18 |
| 2021-03-31 | $296k | 3.0k | 97.27 |
| 2020-12-31 | $293k | 3.1k | 95.94 |
| 2020-09-30 | $2.2M | 23k | 98.91 |
| 2020-06-30 | $1.8M | 14k | 125.27 |